Michelle Gallaher is an award-winning health-tech entrepreneur, and a member of a very rare cohort of women founding and leading publicly listed companies.
Her current focus is on the application of artificial intelligence (AI), particularly in the disruption and advancement of AI in clinical trials and drug discovery and how the health care sector is transforming (or not) in the digital age.
Michelle has successfully established a number of health-related startups, most notably founding Opyl in 2019 (ASX:OPL) and co-founding not-for-profit Women in STEMM Australia in 2014.
Michelle is a non-executive director and sought-after mentor, speaker and advocate.
Michelle is a Victorian Honour Roll for Women inductee, Victorian Telstra Businesswoman and Entrepreneur of the Year, and a winner of Westpac’s 200 Businesses of Tomorrow.
Michelle has an undergraduate degree in applied science, postgraduate qualifications in business and product management, a Global Executive MBA, is a GAICD and FAIM.
